ID: ALA3827977

Max Phase: Preclinical

Molecular Formula: C13H7N5O2

Molecular Weight: 265.23

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=c1oc2ccccc2cc1-c1ccnc2nnnn12

Standard InChI:  InChI=1S/C13H7N5O2/c19-12-9(7-8-3-1-2-4-11(8)20-12)10-5-6-14-13-15-16-17-18(10)13/h1-7H

Standard InChI Key:  NOTUEZRAYCAWPC-UHFFFAOYSA-N

Associated Targets(Human)

Pancreatic alpha-amylase 74 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Alpha-glucosidase MAL12 70 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 265.23Molecular Weight (Monoisotopic): 265.0600AlogP: 1.29#Rotatable Bonds: 1
Polar Surface Area: 86.18Molecular Species: NEUTRALHBA: 7HBD: 0
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 1.25CX LogD: 1.25
Aromatic Rings: 4Heavy Atoms: 20QED Weighted: 0.48Np Likeness Score: -1.41

References

1. Suresh L, Onkara P, Kumar PS, Pydisetty Y, Chandramouli GV..  (2016)  Ionic liquid-promoted multicomponent synthesis of fused tetrazolo[1,5-a]pyrimidines as α-glucosidase inhibitors.,  26  (16): [PMID:27406797] [10.1016/j.bmcl.2016.06.086]

Source